Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 718 clinical trials in Bilthoven, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Tacrolimus for prevention of post-ERCP pancreatitis in moderate- to high-risk patients
The NetherlandsLong‑Term Safety and Efficacy Study of ENTR‑601‑45 and ENTR‑601‑44 in Participants with Duchenne Muscular Dystrophy
The NetherlandsPhase I/II Study of AZD6621 Safety and Efficacy in Adult Men with Metastatic Prostate Cancer
The NetherlandsStudy of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)
The NetherlandsStudy of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
The NetherlandsStudy of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy
The NetherlandsVenetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia
The NetherlandsDiscontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors
The NetherlandsPhase 1/2 Study of VS-7375 with Drug Combination in Patients with Advanced KRAS G12D‑Mutated Solid Tumors
The NetherlandsRituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia
The NetherlandsSafety and Efficacy of TSRA-196 (rnaivt9315 and rnacs24757) in Adults with Lung or Liver Disease due to Alpha‑1 Antitrypsin Deficiency
The NetherlandsPhase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Research focusing on optimizing vaccine effectiveness against multiple infectious diseases, including studies on meningococcal disease and influenza in different age groups.
Novel approaches include investigating optimal vaccination timing and early immunization strategies for enhanced protection.
Advanced studies in breast cancer treatment, examining innovative therapeutic combinations for hormone receptor-positive cases.
Investigations focus on optimizing treatment sequences to improve progression-free survival rates.
Clinical research examining surgical treatments combined with antibiotic therapy for improved patient outcomes.
Studies aim to enhance surgical outcomes through innovative combination therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
